PTC Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. SPY
3. ABBV
4. META
5. FDX
6. IBM
7. NKE
8. MU
9. PFE
10. AWK

Go back to PTC Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update

PTC Therapeutics (PTCT) Posts Smaller-than-Expected Q4 Loss

March 16, 2017 7:33 AM EDT

PTC Therapeutics (NASDAQ: PTCT) reported Q4 EPS of ($0.78), $0.29 better than the analyst estimate of ($1.07). Revenue for the quarter came in at $25.2 million versus the consensus estimate of $24.04 million.

2017 Guidance:

For 2017, PTC expects to achieve ex-U.S. Translarna net sales between $105 and $125 million, assuming... More